Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nutrition (Burbank, Los Angeles County, Calif.)|December 27, 2025
Impact of oral nutritional support adherence on muscle strength, body composition, and general health status in gastrointestinal cancer patients: ONMUS studyAhmet Ozveren, Timucin Cil, Derya Hopanci Bicakli, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 5, 2023
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized StudyEverett E Vokes, Francoise Mornex, Ahmet Sezer, et al.The Lancet. Respiratory Medicine|September 22, 2025
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised studyShun Lu, Oleksandr Vynnychenko, Yaroslav Kulyaba, et al.Oncology Research and Treatment|August 23, 2019
Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre StudyMuhammet Ali Kaplan, Sukru Ozaydin, Halis Yerlikaya, et al.The New England Journal of Medicine|June 2, 2025
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast CancerMario Campone, Michelino De Laurentiis, Komal Jhaveri, et al.The New England Journal of Medicine|November 27, 2024
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal CancerThierry Andre, Elena Elez, Eric Van Cutsem, et al.Lancet (London, England)|January 28, 2025
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trialThierry André, Elena Elez, Heinz-Josef Lenz, et al.Pageof 4